|
|
Parenchymal border macrophages in AD and CAA |
| 1P01AG078106-01 |
|
NIA |
2022 |
|
|
Interplay between meningeal lymphatics, high-density lipoproteins and border macrophages in cerebral amyloid angiopathy |
| 1P01AG078106-01 |
|
NIA |
2022 |
|
|
Cerebral amyloid angiopathy: Role of ApoE, innate immunity, and meningeal lymphatics |
| 1P01AG078106-01 |
|
NIA |
2022 |
|
|
Project 3 - Astrocytic glutamate dysregulation in AD and VCID |
| 1P01AG078116-01 |
|
NIA |
2022 |
|
|
Project 2 - Astrocytic insulin signaling and AD |
| 1P01AG078116-01 |
|
NIA |
2022 |
|
|
Project 4: Consequences of Retrotransposable Element Activation in the Central Nervous System |
| 2P01AG051449-06 |
|
NIA |
2022 |
|
|
Core B - Retrotransposon Genomics, Technology and Analysis Core |
| 2P01AG051449-06 |
|
NIA |
2022 |
|
|
Core C: Mouse Intervention and Neuropathy Core |
| 2P01AG051449-06 |
|
NIA |
2022 |
|
|
Project 3 - Animal Models Examining Neurovasculature |
| 2P01AG052350-06 |
|
NIA |
2022 |
|
|
Pilot and Exploratory Studies Core |
| 2P30AG028740-16 |
|
NIA |
2022 |